These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38041678)
1. Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial. Guo H; Yu J; He T; Chen S; Sun Z; Zhang J; Sun Z; Yang W; Yao B; Yang X; Liu Y; Zhang M; Meng Y; Yang L; Yan H Br J Ophthalmol; 2024 Jul; 108(8):1161-1167. PubMed ID: 38041678 [TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study. Charteris DG; Cro S; Casswell E; Edwards RT; Ezeofor V; Anthony B; Bunce C; Robertson E; Kelly J; Murphy C; Banerjee P; Cornelius VR Health Technol Assess; 2023 Jul; 27(12):1-50. PubMed ID: 37840322 [TBL] [Abstract][Full Text] [Related]
3. Triamcinolone during pars plana vitrectomy for open globe trauma: a pilot randomised controlled clinical trial. Banerjee PJ; Xing W; Bunce C; Woodcock M; Chandra A; Scott RA; Charteris DG Br J Ophthalmol; 2016 Jul; 100(7):949-955. PubMed ID: 26546051 [TBL] [Abstract][Full Text] [Related]
4. Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial. Banerjee PJ; Cornelius VR; Phillips R; Lo JW; Bunce C; Kelly J; Murphy C; Edwards RT; Robertson EL; Charteris DG Trials; 2016 Jul; 17(1):339. PubMed ID: 27449500 [TBL] [Abstract][Full Text] [Related]
6. Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Chen W; Chen H; Hou P; Fok A; Hu Y; Lam DS Retina; 2011 Jun; 31(6):1137-42. PubMed ID: 21317835 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Jonas JB; Söfker A; Degenring R Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Avitabile T; Longo A; Reibaldi A Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521 [TBL] [Abstract][Full Text] [Related]
9. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876 [TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study. Ueno A; Enaida H; Hata Y; Hisatomi T; Nakamura T; Mochizuki Y; Sakamoto T; Ishibashi T Eur J Ophthalmol; 2007; 17(3):392-8. PubMed ID: 17534822 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Munir WM; Pulido JS; Sharma MC; Buerk BM Can J Ophthalmol; 2005 Oct; 40(5):598-604. PubMed ID: 16391623 [TBL] [Abstract][Full Text] [Related]
12. Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy. Lee Y; Kang S; Park YH Korean J Ophthalmol; 2013 Feb; 27(1):28-33. PubMed ID: 23372376 [TBL] [Abstract][Full Text] [Related]
13. A phase III, multi-centre, double-masked randomised controlled trial of adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): statistical analysis plan. Lo JW; Bunce C; Charteris D; Banerjee P; Phillips R; Cornelius VR Trials; 2016 Aug; 17():383. PubMed ID: 27484082 [TBL] [Abstract][Full Text] [Related]
14. Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Cheema RA; Peyman GA; Fang T; Jones A; Lukaris AD; Lim K Ophthalmic Surg Lasers Imaging; 2007; 38(5):365-70. PubMed ID: 17955840 [TBL] [Abstract][Full Text] [Related]
15. Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy. Acar N; Kapran Z; Altan T; Unver YB; Pasaoglu E Jpn J Ophthalmol; 2010 Jul; 54(4):331-7. PubMed ID: 20700802 [TBL] [Abstract][Full Text] [Related]
16. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Hirano Y; Sakurai E; Yoshida M; Ogura Y Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protocol for a randomised controlled trial. Banerjee PJ; Woodcock MG; Bunce C; Scott R; Charteris DG Trials; 2013 Feb; 14():42. PubMed ID: 23406256 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]